Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | CEP170 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CEP170 mRNA | CTD | PMID:22079256 | 1,1-dichloroethene | increases expression | EXP | | 6480464 | vinylidene chloride results in increased expression of CEP170 mRNA | CTD | PMID:26682919 | 17beta-estradiol | affects expression | ISO | CEP170 (Homo sapiens) | 6480464 | Estradiol affects the expression of CEP170 mRNA | CTD | PMID:22574217 | 17beta-estradiol | multiple interactions | ISO | CEP170 (Homo sapiens) | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of CEP170 mRNA | CTD | PMID:30165855 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of CEP170 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Cep170 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CEP170 mRNA | CTD | PMID:33387578 | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of CEP170 mRNA | CTD | PMID:19770486 | aflatoxin B1 | increases methylation | ISO | CEP170 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of CEP170 intron | CTD | PMID:30157460 | ammonium chloride | affects expression | ISO | Cep170 (Rattus norvegicus) | 6480464 | Ammonium Chloride affects the expression of CEP170 mRNA | CTD | PMID:16483693 | aristolochic acid A | decreases expression | ISO | CEP170 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of CEP170 mRNA | CTD | PMID:33212167 | arsenite(3-) | multiple interactions | ISO | CEP170 (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to CEP170 mRNA] | CTD | PMID:32406909 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of CEP170 mRNA | CTD | PMID:19770486 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | CEP170 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 | bisphenol A | decreases expression | ISO | Cep170 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of CEP170 mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CEP170 mRNA | CTD | PMID:33221593 | bisphenol A | affects expression | ISO | Cep170 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of CEP170 mRNA | CTD | PMID:30816183 | bisphenol F | multiple interactions | ISO | CEP170 (Homo sapiens) | 6480464 | [bisphenol F co-treated with Fulvestrant] results in increased methylation of CEP170 gene | CTD | PMID:31601247 | bisphenol F | increases expression | ISO | CEP170 (Homo sapiens) | 6480464 | bisphenol F results in increased expression of CEP170 protein | CTD | PMID:34186270 | caffeine | affects phosphorylation | ISO | CEP170 (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of CEP170 protein | CTD | PMID:35688186 | choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CEP170 mRNA | CTD | PMID:20938992 | cobalt dichloride | decreases expression | ISO | CEP170 (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of CEP170 mRNA | CTD | PMID:19320972 | cobalt dichloride | increases expression | ISO | CEP170 (Homo sapiens) | 6480464 | cobaltous chloride results in increased expression of CEP170 mRNA | CTD | PMID:19376846 | copper(II) sulfate | increases expression | ISO | CEP170 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of CEP170 mRNA | CTD | PMID:19549813 | coumarin | affects phosphorylation | ISO | CEP170 (Homo sapiens) | 6480464 | coumarin affects the phosphorylation of CEP170 protein | CTD | PMID:35688186 | crocidolite asbestos | decreases expression | EXP | | 6480464 | Asbestos and Crocidolite results in decreased expression of CEP170 mRNA | CTD | PMID:29279043 | elemental selenium | decreases expression | ISO | CEP170 (Homo sapiens) | 6480464 | Selenium results in decreased expression of CEP170 mRNA | CTD | PMID:19244175 | enzyme inhibitor | multiple interactions | ISO | CEP170 (Homo sapiens) | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CEP170 protein | CTD | PMID:23301498 | flavonoids | increases expression | ISO | Cep170 (Rattus norvegicus) | 6480464 | Flavonoids results in increased expression of CEP170 mRNA | CTD | PMID:18035473 | flutamide | decreases expression | ISO | Cep170 (Rattus norvegicus) | 6480464 | Flutamide results in decreased expression of CEP170 mRNA | CTD | PMID:24136188 | folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CEP170 mRNA | CTD | PMID:20938992 | folic acid | decreases expression | EXP | | 6480464 | Folic Acid results in decreased expression of CEP170 mRNA | CTD | PMID:25629700 | FR900359 | affects phosphorylation | ISO | CEP170 (Homo sapiens) | 6480464 | FR900359 affects the phosphorylation of CEP170 protein | CTD | PMID:37730182 | fulvestrant | multiple interactions | ISO | CEP170 (Homo sapiens) | 6480464 | [bisphenol F co-treated with Fulvestrant] results in increased methylation of CEP170 gene | CTD | PMID:31601247 | gentamycin | increases expression | ISO | Cep170 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of CEP170 mRNA | CTD | PMID:22061828 and PMID:33387578 | inulin | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CEP170 mRNA | CTD | PMID:36331819 | ivermectin | decreases expression | ISO | CEP170 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of CEP170 protein | CTD | PMID:32959892 | L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CEP170 mRNA | CTD | PMID:20938992 | N(4)-hydroxycytidine | decreases expression | EXP | | 6480464 | N(4)-hydroxycytidine results in decreased expression of CEP170 mRNA | CTD | PMID:37748715 | nefazodone | decreases expression | ISO | Cep170 (Rattus norvegicus) | 6480464 | nefazodone results in decreased expression of CEP170 mRNA | CTD | PMID:24136188 | nimesulide | decreases expression | ISO | Cep170 (Rattus norvegicus) | 6480464 | nimesulide results in decreased expression of CEP170 mRNA | CTD | PMID:24136188 | oxaliplatin | multiple interactions | ISO | Cep170 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of CEP170 mRNA | CTD | PMID:25729387 | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of CEP170 mRNA | CTD | PMID:17562736 | perfluorooctane-1-sulfonic acid | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CEP170 mRNA | CTD | PMID:36331819 | piroxicam | increases expression | ISO | CEP170 (Homo sapiens) | 6480464 | Piroxicam results in increased expression of CEP170 mRNA | CTD | PMID:21858171 | potassium chromate | decreases expression | ISO | CEP170 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of CEP170 mRNA | CTD | PMID:22079256 | potassium chromate | multiple interactions | ISO | CEP170 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CEP170 mRNA | CTD | PMID:22079256 | propiconazole | increases expression | EXP | | 6480464 | propiconazole results in increased expression of CEP170 mRNA | CTD | PMID:21278054 | quercetin | increases phosphorylation | ISO | CEP170 (Homo sapiens) | 6480464 | Quercetin results in increased phosphorylation of CEP170 protein | CTD | PMID:35688186 | selenium atom | decreases expression | ISO | CEP170 (Homo sapiens) | 6480464 | Selenium results in decreased expression of CEP170 mRNA | CTD | PMID:19244175 | succimer | multiple interactions | EXP | | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CEP170 mRNA | CTD | PMID:21641980 | tert-butyl hydroperoxide | increases expression | ISO | CEP170 (Homo sapiens) | 6480464 | tert-Butylhydroperoxide results in increased expression of CEP170 mRNA | CTD | PMID:15336504 | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of CEP170 mRNA | CTD | PMID:27339419 and PMID:31919559 | titanium dioxide | decreases expression | EXP | | 6480464 | titanium dioxide results in decreased expression of CEP170 mRNA | CTD | PMID:29264374 | topotecan | decreases expression | ISO | Cep170 (Rattus norvegicus) | 6480464 | Topotecan results in decreased expression of CEP170 mRNA | CTD | PMID:25729387 | topotecan | multiple interactions | ISO | Cep170 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of CEP170 mRNA | CTD | PMID:25729387 | trichloroethene | increases expression | ISO | CEP170 (Homo sapiens) | 6480464 | Trichloroethylene results in increased expression of CEP170 mRNA and Trichloroethylene results in increased expression of CEP170 protein | CTD | PMID:19109764 | triptonide | decreases expression | EXP | | 6480464 | triptonide results in decreased expression of CEP170 mRNA | CTD | PMID:33045310 | tungsten | decreases expression | EXP | | 6480464 | Tungsten results in decreased expression of CEP170 mRNA | CTD | PMID:30912803 | valproic acid | decreases expression | ISO | CEP170 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of CEP170 mRNA | CTD | PMID:23179753 | vitamin E | decreases expression | ISO | CEP170 (Homo sapiens) | 6480464 | Vitamin E results in decreased expression of CEP170 mRNA | CTD | PMID:19244175 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
Welcome {{ username}}
Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{gene.symbol}}: {{ gene.description }}
|
| You must be logged in to use this feature |
| {{ loginError }} |
|
|
Analyze GeneStrainQTL List |
 Gene Annotator (Functional Annotation) unavailable |
 Gene Annotator (Annotation Distribution) unavailable |
 Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
 InterViewer (Protein-Protein Interactions) unavailable |
 Gviewer (Genome Viewer) unavailable |
 Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
 Gene Annotator (Annotation Comparison) unavailable |
 OLGA (Gene List Generator) unavailable |
 |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
 MOET (Multi-Ontology Enrichement) unavailable |
 GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
|
||||||||||
Gene Ontology Annotations Click to see Annotation Detail View
Biological Process
Cellular Component
Molecular Function
